AR002104A1 - Agentes antifungicos de peptidos ciclicos. - Google Patents

Agentes antifungicos de peptidos ciclicos.

Info

Publication number
AR002104A1
AR002104A1 ARP960102722A AR10272296A AR002104A1 AR 002104 A1 AR002104 A1 AR 002104A1 AR P960102722 A ARP960102722 A AR P960102722A AR 10272296 A AR10272296 A AR 10272296A AR 002104 A1 AR002104 A1 AR 002104A1
Authority
AR
Argentina
Prior art keywords
antifungal agents
cyclic peptide
alkyl
peptide antifungal
alkoxy
Prior art date
Application number
ARP960102722A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR002104A1 publication Critical patent/AR002104A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se proporcionan formulaciones farmacéuticas y procedimientos para inhibir la actividad fúngica y parasitaria, usando un compuesto de fórmula (I), en laque R2 es (II), cada R2a es, independientemente, hidroxi, halo, nitro, amino, trifluormetilo, alquilo C1-C6, alcoxi C1-C6 o alquiltio C1-C6; a es 1, 2, 3 ó4; R3 es alquilo C1-C12, alcoxi C1-C12 u -O-(CH2)m-[O-(CH2)n]p-O-(alquilo C1-C12); m es 2, 3 ó 4; n es 2, 3 ó 4; y p es 0 ó 1; o una salfarmacéuticamente aceptable de los mismos.
ARP960102722A 1995-05-26 1996-05-24 Agentes antifungicos de peptidos ciclicos. AR002104A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45133795A 1995-05-26 1995-05-26

Publications (1)

Publication Number Publication Date
AR002104A1 true AR002104A1 (es) 1998-01-07

Family

ID=23791818

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102722A AR002104A1 (es) 1995-05-26 1996-05-24 Agentes antifungicos de peptidos ciclicos.

Country Status (11)

Country Link
US (1) US5786325A (es)
EP (1) EP0744407B1 (es)
AR (1) AR002104A1 (es)
AT (1) ATE225804T1 (es)
AU (1) AU5799096A (es)
DE (1) DE69624167T2 (es)
ES (1) ES2180699T3 (es)
IL (1) IL118331A0 (es)
PE (1) PE37897A1 (es)
WO (1) WO1996037509A1 (es)
ZA (1) ZA964011B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965525A (en) * 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
US6743777B1 (en) * 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US6384013B1 (en) 1992-03-19 2002-05-07 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
WO1999006062A1 (en) * 1997-08-04 1999-02-11 Eli Lilly And Company Cyclic peptide antifungal agents
US6323176B1 (en) 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
JP2002528388A (ja) 1998-08-20 2002-09-03 イーライ リリー アンド カンパニー 環改変された環状ペプチドアナログ
PT1137663E (pt) 1998-12-09 2006-12-29 Lilly Co Eli Purificação de compostos ciclopéptidos equinocandina
EP1582204B1 (en) * 1999-03-03 2013-09-25 Eli Lilly & Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
DE60030415T2 (de) 1999-03-03 2007-08-30 Eli Lilly And Co., Indianapolis Bildung und anionenaustausch von inneren kristallinen ammoniumsalzen des echinocandins b
JP2002538097A (ja) 1999-03-03 2002-11-12 イーライ リリー アンド カンパニー 薬学的経口ｅｃｂ処方物および組成物の作製方法
ATE248187T1 (de) * 1999-03-03 2003-09-15 Lilly Co Eli Echinocandin-kohlenhydrate-komplexe
AU5871000A (en) * 1999-06-11 2001-01-02 Paul G. Abrams High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
JP2004536034A (ja) * 2001-01-08 2004-12-02 ネオルクス コーポレイション 治療的および診断的化合物、組成物および方法
AU2002364552A1 (en) 2001-12-13 2003-06-30 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
US6991800B2 (en) * 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
EP1620422A2 (en) * 2003-04-30 2006-02-01 The Institutes for Pharmaceutical Discovery, LLC Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
US10825328B2 (en) 2017-07-03 2020-11-03 Motorola Solutions, Inc. Apparatus for managing a plurality of devices in a portable communication system

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320052A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293488A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912B nucleus
US5166135A (en) * 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
DK173802B1 (da) * 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
CA2037957A1 (en) * 1990-03-12 1991-09-13 Merck & Co., Inc. N-acylated cyclohexapeptide compounds
GB2241956A (en) * 1990-03-16 1991-09-18 Merck & Co Inc N-acylated cyclohexapeptide compounds
IE910892A1 (en) * 1990-03-19 1991-09-25 Merck & Co Inc Lipopeptide compounds
US5049546A (en) * 1990-03-19 1991-09-17 Merck & Co., Inc. Antibiotic agents
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
US5310726A (en) * 1990-03-19 1994-05-10 Merck & Co., Inc. Lipopeptide compounds
IL97347A0 (en) * 1990-03-19 1992-05-25 Merck & Co Inc Lipopeptide derivatives and antimicrobial compositions containing them
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
FI912873A (fi) * 1990-06-18 1991-12-19 Fujisawa Pharmaceutical Co Ny polypeptidfoerening och foerfarande foer dess framstaellning.
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
US5233023A (en) * 1991-07-30 1993-08-03 Merck & Co., Inc. Process for phosphate ester compounds of certain cyclohexapeptides
IL122315A (en) * 1992-03-19 2002-03-10 Lilly Co Eli Cyclic peptides and antifungal pharmaceutical compositions containing them
US6268338B1 (en) * 1993-04-30 2001-07-31 Merck & Co., Inc. Cyclohexapeptidyl amine compounds
US5948753A (en) * 1993-05-04 1999-09-07 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
AU674233B2 (en) * 1993-05-04 1996-12-12 Merck & Co., Inc. Cyclohexapeptidyl aminoalkyl ethers
US5541160A (en) * 1994-04-04 1996-07-30 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5514651A (en) * 1994-09-16 1996-05-07 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds

Also Published As

Publication number Publication date
EP0744407B1 (en) 2002-10-09
ATE225804T1 (de) 2002-10-15
DE69624167D1 (de) 2002-11-14
WO1996037509A1 (en) 1996-11-28
PE37897A1 (es) 1997-10-09
ES2180699T3 (es) 2003-02-16
US5786325A (en) 1998-07-28
EP0744407A3 (en) 1998-05-20
DE69624167T2 (de) 2003-02-13
IL118331A0 (en) 1996-09-12
EP0744407A2 (en) 1996-11-27
AU5799096A (en) 1996-12-11
ZA964011B (en) 1997-11-20

Similar Documents

Publication Publication Date Title
AR002104A1 (es) Agentes antifungicos de peptidos ciclicos.
PT561639E (pt) Agentes antifungicos de peptido ciclico e processos para a sua preparacao
GEP19991870B (en) Alkyl Amine Derivatives of Substituted Quinoxaline 2,3-Diones as Glutamate Receptor Antagonists
EA199700307A1 (ru) Циклические пептидные антигрибковые агенты
DK0583485T3 (da) Ethanolaminderivater med sympathomimetiske og anti-pollakisuria-virkninger
FI860878A (fi) Aminosyraderivat och foerfarande foer deras framstaellning.
PE38297A1 (es) Agentes antifungicos de peptidos ciclicos
BR0314844A (pt) Novo composto
DK0757058T3 (da) Cykliske peptider som anti-fungale midler
HUP0100184A2 (hu) Szubsztituált 2-(benzil-amino)-2-fenil-acetamid-vegyületek és ezeket tartalmazó gyógyszerkészítmények
FI892637A (fi) Menetelmä valmistaa farmakologisesti arvokasta kefeemiyhdistettä
NZ302072A (en) 1,3-diamino propyl stereomeric derivatives and organic acid and inorganic salts of their amine intermediates in the preparation of retroviral protease inhibitors
DK0399519T3 (da) Potensering af celleformidlet immunitet under anvendelse af polyaminderivater
EP0744404A3 (en) Cyclic peptide antifungal agents
DE69629474D1 (de) Antifungale tetrahydrofurane
SE9603285D0 (sv) New compounds
HK1019600A1 (en) Camtothecin-skeleton compounds isolated from mappia foetida and the use thereof as syntones for novel medicaments as well as therapeutical agents
WO2000078793A3 (en) Antimicrobial agents
ECSP961755A (es) Agentes antifungicos de peptidos ciclicos (caso x-9249)
DE69205383D1 (de) N,N',N'-trisubstituierte 5-Bisaminomethylen-1,3-Dioxan-4,6-Dione als Acyl-CoA: Cholesterol-Acyltransferasehemmer.